Top

Published in:

Open Access 01-12-2011 | Letter to the Editors

Centrilobular emphysema combined with pulmonary fibrosis results in improved survival: a response

Authors: Vincent Cottin, Jean-François Cordier, Athol U Wells

Published in: Fibrogenesis & Tissue Repair | Issue 1/2011

Abstract

Better survival in combined pulmonary fibrosis and emphysema than in lone pulmonary fibrosis: bias or reality? A response to Centrilobular emphysema combined with pulmonary fibrosis results in improved survival by Todd et al., Fibrogenesis & Tissue Repair 2011, 4:6.

Please see related letter http://fibrogenesis.com/content/4/1/17

Todd NW, Jeudy J, Lavania S, Franks TJ, Galvin JR, Deepak J, Britt EJ, Atamas SP: Centrilobular emphysema combined with pulmonary fibrosis results in improved survival. Fibrogenesis Tissue Repair. 2011, 4: 6-10.1186/1755-1536-4-6.PubMedCentralCrossRefPubMed

Cottin V, Nunes H, Brillet PY, Delaval P, Devouassoux G, Tillie-Leblond I, Israel-Biet D, Court-Fortune I, Valeyre D, Cordier JF, Groupe d'Etude et de Recherche sur les Maladies "Orphelines" Pulmonaires (GERM"O"P): Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity. Eur Respir J. 2005, 26: 586-593. 10.1183/09031936.05.00021005.CrossRefPubMed

Mejia M, Carrillo G, Rojas-Serrano J, Estrada A, Suarez T, Alonso D, Barrientos E, Gaxiola M, Navarro C, Selman M: Idiopathic pulmonary fibrosis and emphysema: decreased survival associated with severe pulmonary arterial hypertension. Chest. 2009, 136: 10-15. 10.1378/chest.08-2306.CrossRefPubMed

Antoniou KM, Hansell DM, Rubens MB, Marten K, Desai SR, Siafakas NM, Nicholson AG, du Bois RM, Wells AU: Idiopathic pulmonary fibrosis: outcome in relation to smoking status. Am J Respir Crit Care Med. 2008, 177: 190-194.CrossRefPubMed

Akira M, Inoue Y, Kitaichi M, Yamamoto S, Arai T, Toyokawa K: Usual interstitial pneumonia and nonspecific interstitial pneumonia with and without concurrent emphysema: thin-section CT findings. Radiology. 2009, 251: 271-279. 10.1148/radiol.2511080917.CrossRefPubMed

Kiakouama L, Cottin V, Glerant JC, Bayle JY, Mornex JF, Cordier JF: Conditions associated with severe carbon monoxide diffusion coefficient reduction. Respir Med. 2011, 105: 1248-56. 10.1016/j.rmed.2011.03.004.CrossRefPubMed

Title: Centrilobular emphysema combined with pulmonary fibrosis results in improved survival: a response
Authors: Vincent Cottin
Jean-François Cordier
Athol U Wells
Publication date: 01-12-2011
Publisher: BioMed Central
Published in: Fibrogenesis & Tissue Repair / Issue 1/2011
Electronic ISSN: 1755-1536
DOI: https://doi.org/10.1186/1755-1536-4-16

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2011

Elevated transforming growth factor β and mitogen-activated protein kinase pathways mediate fibrotic traits of Dupuytren's disease fibroblasts

Thrombospondin 1 in hypoxia-conditioned media blocks the growth of human microvascular endothelial cells and is increased in systemic sclerosis tissues

Hyaluronidase recruits mesenchymal-like cells to the lung and ameliorates fibrosis

What is new in the liver sinusoids? meeting report, 16th International Symposium on Cells of the Hepatic Sinusoid (ISCHS)

TLR9-induced interferon β is associated with protection from gammaherpesvirus-induced exacerbation of lung fibrosis

Mesenchymal stem cells: from experiment to clinic

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials